Selective efficient photocatalytic degradation of antibiotics and direct Z-type migration pathway for hierarchical core-shell TiO2/g-C3N4 composites.

Constructing superior Z-type photocatalytic heterojunction is beneficial to effectively enlarge interface contact, improve the photo-generated carrier separation rate, and retain the high redox ability. In this work, we designed a hierarchical core-shell g-C3N4/TiO2 structure to build Z-type heterojunction via combining simple template method and pyrolysis process. A close-knit Z-type heterojunction was constructed using TiO2 as a thick core and g-C3N4 as an ultra-thin shell. The effects of lamp source, wavelength, tetracycline (TC) concentration, and photocatalyst dose on the degradation performance on TC of g-C3N4/TiO2 were inspected. 0.1TiO2/g-C3N4 photocatalyst had the best degradation rate and highest removal rate within 30 min, and its degradation rate was about 49, 23, and 5 times than pure g-C3N4, TiO2, and commercial TiO2/g-C3N4 in respect. Moreover, compared with degradation ability under Xenon lamp, LED irradiation for g-C3N4/TiO2 composites showed a remarkable selective degradation. The fast and efficient Z-type transfer pathway of 0.1 g-C3N4/TiO2 was realized by forming an optimized interface and abundant surface active sites ascribed to the combined action of thick TiO2 core and ultra-thin g-C3N4 shell. In addition, the degradation intermediates were analyzed by LC-MS and suggested pathways of degradation. The work could provide novel design concept to obtain reliable Z-type photocatalysts with hierarchical core-shell structure applied in degradation of antibiotic wastewater.

Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.

Background and Aim: The impact of liver function test (LFTs) abnormality on adverse clinical outcomes in coronavirus disease 2019 (COVID-19) patients remains controversial. The aim of this study was to assess the impact of abnormal LFTs on clinical outcomes in a large cohort of hospitalized patients with COVID-19. Methods: We retrospectively collected data on 2,912 consecutive patients with COVID-19 who were admitted to a makeshift hospital in China between 5 February and 23 March 2020. The association between LFTs abnormalities (baseline and peak values) and clinical outcomes was measured by using Cox regression models. Results: On admission 1,414 patients (48.6%) had abnormal LFTs, with alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), alkaline phosphatase (ALP), and gamma-glutamyltransferase (GGT) elevation in 662 (22.7%), 221 (7.6%), 52 (1.8%), 135 (4.6%), and 536 (18.5%) patients, respectively, and hypoalbuminemia in 737 (25.3%) patients. During a median 13 (IQR: 8-19) days of hospitalization, 61 patients (2.1%) died, 106 patients (3.6%) admitted to intensive care unit (ICU), and 75 patients (2.6%) required mechanical ventilation. After adjustment for confounders, baseline abnormal LFTs were independently associated with increased risks of mortality (adjusted HR 3.66, 95%CI 1.64-8.19, p = 0.002), ICU admission (adjusted HR 3.12 95%CI 1.86-5.23, p < 0.001), and mechanical ventilation (adjusted HR 3.00, 95%CI 1.63-5.52, p < 0.001), which was homogeneous across the severity of COVID-19 infection. Among the parameters of LTFs, the associations with the outcomes were more pronounced for AST and albumin abnormality. In contrast, ALT elevation was not significantly associated with those outcomes. Similar results were observed for peak values of LFTs during hospitalization. Conclusions: Abnormality of AST, albumin, TBIL, ALP, and GGT but not ALT were independently associated with adverse outcomes.